ESC Professional Premium Access

Everolimus-eluting bioresorabable scaffold system in the treatment of cardiac allograft vasculopathy: the cardiac allograft reparative therapy (CART) prospective multicentre pilot study

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Congress Presentation

About the speaker

Doctor Simone Fezzi

The Lambe Institute for Translational Research, University of Galway, Galway (Ireland)
0 follower

5 more presentations in this session

Takotsubo's cardiomyopathy in patients with pre-existing autoimmune diseases : a national inpatient sample analysis

Speaker: Doctor S. Kannayiram (Chicago, US)


Dissecting genetics in hypothyroidism as an independent risk factor in atherosclerotic disease

Speaker: Mr S. Rand (Copenhagen, DK)


Endothelial glycocalyx improvement after six months and one-year of antiretroviral therapy in treatment naive patients with human immunodeficiency virus

Speaker: Doctor H. Triantafyllidi (Athens, GR)


Abnormal immune activation and fibrosis of epicardial adipose tissue in people living with HIV: results from the PIECVIH study.

Speaker: Professor F. Boccara (Paris, FR)


Comparing cardiac MRI and lung PET/CT after completion of tuberculosis treatment - preliminary findings of participants co-enrolled into the StatinTB trial and Cardiac Imaging After TB (CIA-TB) study

Speaker: Doctor S. Mukasa (Cape Town, ZA)


Access the full session

Autoimmune, chronic inflammatory disorders, HIV and cardiovascular disease

Speakers: Doctor S. Fezzi, Doctor S. Kannayiram, Mr S. Rand, Doctor H. Triantafyllidi, Professor F. Boccara...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb